167 related articles for article (PubMed ID: 27259306)
1. Comparison of SPE, IFE, and FLC in Monitoring Patients with Multiple Myeloma After Autologous Stem Cell Transplantation.
Li W; Zhou JZ; Chang HR; Dai LJ; Zhu ZL; Feng YF; Gong FR; Wu DP
Cell Biochem Biophys; 2015 Dec; 73(3):643-7. PubMed ID: 27259306
[TBL] [Abstract][Full Text] [Related]
2. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of unexpected protein bands in multiple myeloma patients after autologous stem cell transplantation.
Kim SK; Jeong TD; Kim SY; Lee W; Chun S; Suh CW; Min WK
Clin Biochem; 2014 May; 47(7-8):588-92. PubMed ID: 24582697
[TBL] [Abstract][Full Text] [Related]
4. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
5. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
[TBL] [Abstract][Full Text] [Related]
6. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Heavy/Light Chain Ratio and Matched Pair Suppression Increase Residual Disease Detection Sensitivity in Patients With Multiple Myeloma With Deep Responses.
Miyazaki K; Suzuki K
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):293-296. PubMed ID: 29472112
[TBL] [Abstract][Full Text] [Related]
8. Heavy/light chain assay in the monitoring of multiple myeloma.
Ting HY; Sthaneshwar P; Bee PC; Shanmugam H; Lim M
Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
[TBL] [Abstract][Full Text] [Related]
9. Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantation.
Alejandre ME; Pavlovsky MA; Remaggi G; Corrado C; Fernandez I; Milone G; Pavlovsky A; Madalena L; Pandolfo M; Facio ML; Bresciani P; Pavlovsky S; Pizzolato MA
Clin Chem Lab Med; 2012 Apr; 50(6):1093-7. PubMed ID: 22706252
[TBL] [Abstract][Full Text] [Related]
10. Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.
Giles HV; Drayson MT; Kishore B; Pawlyn C; Kaiser M; Cook G; de Tute R; Owen RG; Cairns D; Menzies T; Davies FE; Morgan GJ; Pratt G; Jackson GH
Blood Cancer J; 2024 Mar; 14(1):50. PubMed ID: 38499538
[TBL] [Abstract][Full Text] [Related]
11. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
Nowrousian MR; Brandhorst D; Sammet C; Kellert M; Daniels R; Schuett P; Poser M; Mueller S; Ebeling P; Welt A; Bradwell AR; Buttkereit U; Opalka B; Flasshove M; Moritz T; Seeber S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8706-14. PubMed ID: 16361557
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.
Parmar H; Al Saleh AS; Visram A; Warsame R; Kourelis T; Gonsalves W; Dingli D; Muchtar E; Hayman S; Kapoor P; Buadi F; Dispenzieri A; Lacy M; Gertz M; Kumar S
Transplant Cell Ther; 2021 Apr; 27(4):309.e1-309.e5. PubMed ID: 33836869
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
15. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
16. Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma.
Puig N; Contreras MT; Agulló C; Martínez-López J; Oriol A; Blanchard MJ; Ríos R; Martín J; Iñigo MB; Sureda A; Hernández MT; de la Rubia J; González-Calle V; Krsnik I; Cabañas V; Palomera L; Moraleda JM; Bargay J; Cedena MT; Paiva B; Rosiñol L; Bladé J; San Miguel J; Lahuerta JJ; Mateos MV
Blood Adv; 2022 Jun; 6(11):3234-3239. PubMed ID: 35157768
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
Vermeersch P; Van Hoovels L; Delforge M; Mariën G; Bossuyt X
Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849
[TBL] [Abstract][Full Text] [Related]
18. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
Jung S; Kim M; Lim J; Kim Y; Han K; Min CK; Min WS
Korean J Lab Med; 2008 Jun; 28(3):169-73. PubMed ID: 18594166
[TBL] [Abstract][Full Text] [Related]
19. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.
Levinson SS
Clin Chem Lab Med; 2011 Nov; 49(11):1801-4. PubMed ID: 21663562
[TBL] [Abstract][Full Text] [Related]
20. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
